Literature DB >> 22871943

Severe hyperkalemia in critically ill patients treated with prophylactic doses of enoxaparin.

Christine Danguy, Patrick Biston, Eric Carlier, Pierre Defrance, Michael Piagnerelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22871943     DOI： 10.1007/s00134-012-2653-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Effect of prophylactic treatment with low-molecular-weight heparin bemiparin sodium on serum potassium levels: a prospective observational study.

Authors:  Olga H Torres; Nerea Hernandez; Esther Francia; Montserrat Barcelo; Jose Mateo; Domingo Ruiz
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

2.  Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Susan R Kahn; Wendy Lim; Andrew S Dunn; Mary Cushman; Francesco Dentali; Elie A Akl; Deborah J Cook; Alex A Balekian; Russell C Klein; Hoang Le; Sam Schulman; M Hassan Murad
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Variations of serum potassium level and risk of hyperkalemia in inpatients receiving low-molecular-weight heparin.

Authors:  Giuseppe Gheno; Leonardo Cinetto; Carmelo Savarino; Sandro Vellar; Maurizio Carraro; Massimo Randon
Journal:  Eur J Clin Pharmacol       Date:  2003-07-08       Impact factor: 2.953

Review 4.  Heparin-induced aldosterone suppression and hyperkalemia.

Authors:  J R Oster; I Singer; L M Fishman
Journal:  Am J Med       Date:  1995-06       Impact factor: 4.965

5.  Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels.

Authors:  Girish M Bengalorkar; N Sarala; P N Venkatrathnamma; T N Kumar
Journal:  J Pharmacol Pharmacother       Date:  2011-10
  5 in total
  2 in total

1.  Profound hyperkalemia associated with thromboprophylactic enoxaparin.

Authors:  Michael Joseph Scalese
Journal:  Ther Adv Drug Saf       Date:  2016-03-07

Review 2.  Drug-induced hyperkalemia.

Authors:  Chaker Ben Salem; Atef Badreddine; Neila Fathallah; Raoudha Slim; Houssem Hmouda
Journal:  Drug Saf       Date:  2014-09       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.